In a December 9, 2025 Washington Examiner op-ed, WLF Legal Policy Advisory Board member and former Food & Drug Administration (FDA) Chief Counsel, Dan Troy, criticized federal regulators’ approach to direct-to-consumer (DTC) advertising of prescription drugs.
On January 6, 2026, WLF urged the Supreme Court to grant review and reverse a Sixth Circuit decision that blessed certifying a disparate-impact damages class that included many uninjured members....
A recent oral argument revealed that whether Congress meant private parties to enforce part of a law regulating investment is a close question.
September 19, 2005 | 12 - 1 am
This site uses cookies for performance, site traffic analysis, and social media purposes. Find out more about our cookie policy here. You can adjust your preferences in cookie settings.